Randomized controlled trials are the best way of testing therapeutic products to determine if they perform as expected and actually make a difference in treating a specific disease. Once preliminary evidence from phase II studies reveals that a treatment is probably effective, phase III trials are carried out to fully examine the risk/benefit profile of an experimental drug in a broader population over a longer period of time.
Time to abandon placebo control in pivotal phase III trials?
CIPRIANI, Andrea
2015-01-01
Abstract
Randomized controlled trials are the best way of testing therapeutic products to determine if they perform as expected and actually make a difference in treating a specific disease. Once preliminary evidence from phase II studies reveals that a treatment is probably effective, phase III trials are carried out to fully examine the risk/benefit profile of an experimental drug in a broader population over a longer period of time.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.